000 | 01669cam a2200325 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
008 | 110305s2010 ua d f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aM.Sc | ||
099 | _aCai01.11.28.M.Sc.2010.Ta.F | ||
100 | 0 | _aTahani Ahmed Mohamed Hassan | |
245 | 1 | 0 |
_aFibroblast growth factor - 23 in children with chronic renal failure / _cTahani Ahmed Mohamed Hassan ; Supervised Fatina Fadel , Happy Kayser Dawod , Layla Ahmed Rashid |
246 | 1 | 5 | _aقياس معدل مادة الفيبروبلاست رقم 23 فى دم الاطفال الذين يعانون من الفشل الكلوى المزمن |
260 |
_aCairo : _bTahani Ahmed Mohamed Hassan , _c2010 |
||
300 |
_a131 P. : _bcharts ; _c25cm |
||
502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics | ||
520 | _aDysregulation of the FGF - 23 - klotho endocrine axis may be involved in the mechanism by which CKD patient's fail to maintain phosphate homeostasis . In fact serum FGF - 23 - level are increased with advancing stages of CKD . The study was to investigate FGF - 23 - level in CKD patients who were under conservative treatment and ESRD patient who were under hemodialysis | ||
530 | _aIssued also as CD | ||
653 | 4 | _aChronic kidney disease | |
653 | 4 | _aEnad-Stage renal disease | |
653 | 4 | _aFibroblast growth factor No 23 | |
700 | 0 |
_aFatina Fadel , _eSupervisor |
|
700 | 0 |
_aHappy Kayser Dawod , _eSupervisor |
|
700 | 0 |
_aLayla Ahmed Rashid , _eSupervisor |
|
905 |
_aNazla _eRevisor |
||
905 |
_aSoheir _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c33194 _d33194 |